Fast food Films: Best Little Girl in World - Taylor 9842 Professional Waterproof Digital Thermometer Reduce the risk of cross-contamination with Taylor’s instant reading thermometers with antibacterial Safe-T-Guard(TM) case. Unique case design inhibits bacterial growth and doubles as a calibration wrench. Dial models feature a 5″ stem and a 0 - 220 […]

Heat shock inhibits lipopolysaccharide-induced tissue factor activity in human whole blood
Background: During gram-negative sepsis, lipopolysaccharide (LPS) induces tissue factor expression on monocytes. The resulting disseminated intravascular coagulation leads to tissue ischemia and worsens the prognosis of septic patients. There are indications, that fever reduces the mortality of sepsis, the effect on tissue factor activity on monocytes is unknown. Therefore, we investigated whether heat shock modulates LPS-induced tissue factor activity in human blood. Methods: Whole blood samples and leukocyte suspensions, respectively, from healthy probands (n = 12) were incubated with LPS for 2 hours under heat shock conditions (43 C) or control conditions (37 C), respectively. Subsequent to further 3 hours of incubation at 37 C the clotting time, a measure of tissue factor expression, was determined. Cell integrity was verified by trypan blue exclusion test and FACS analysis. Results: Incubation of whole blood samples with LPS for 5 hours at normothermia resulted in a significant shortening of clotting time from 357 108 sec to 82 8 sec compared to samples incubated without LPS (n = 12; p < 0.05). This LPS effect was mediated by tissue factor, as inhibition with active site-inhibited factor VIIa (ASIS) abolished the effect of LPS on clotting time. Blockade of protein synthesis using cycloheximide demonstrated that LPS exerted its procoagulatory effect via an induction of tissue factor expression. Upon heat shock treatment, the LPS effect was blunted: clotting times were 312 66 s in absence of LPS and 277 65 s in presence of LPS (n = 8; p > 0.05). Similarly, heat shock treatment of leukocyte suspensions abolished the LPS-induced tissue factor activity. Clotting time was 73 31 s, when cells were treated with LPS (100 ng/mL) under normothermic conditions, and 301 118 s, when treated with LPS (100 ng/mL) and heat shock (n = 8, p < 0.05). Control experiments excluded cell damage as a potential cause of the observed heat shock effect. Conclusion: Heat shock treatment inhibits LPS-induced tissue factor activity in human whole blood samples and isolated leukocytes.

Tai-Chi for health
Tai-Chi for health Customer Review: ..disappointed.. Upon inital use of this tape, I felt that it could have gone to a more advanced level. Although it does an adequate job of reviewing basic postures. What is lacking is a thorough workout so that a user will want to use this tape as […]

The 5, 10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: a case series and review of the literature
Background: The true relationship between methylenetetrahydrofolate reductase C677T homozygosity and risk of recurrent spontaneous abortion is unknown, and it is unclear if women with these mutations should be anticoagulated during pregnancy.ObjectivesWe report a series of 8 patients with this issue and review the current literature. Methods: 8 patients (3 of whom were actively pregnant) were referred with histories of spontaneous fetal loss; hypercoaguability work-ups revealed each were homozygous for the MTHFR C677T mutation without other thrombophilias. Results: In the 3 women who have conceived, treatment with LMW heparin during pregnancy led to two full-term births and one additional pregnancy without complication. For the 5 who have not, we recommended treatment with LMW heparin upon conception. Conclusion: We provide evidence to support the relationship between MTHFR C677T mutations and recurrent fetal loss, and to suggest that anticoagulation of these patients during pregnancy can lead to a successful pregnancy outcome.

This entry was posted on Monday, December 31st, 2007 at 10:10 am and is filed under Health. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.